ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 2604

$1.8M Total Retail Price of All Prescriptions

Rank: 3 out of 2604

807 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 807 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 807 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 23,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 1,213 876 S3 1 1
LEVOTHYROXINE SODIUM 932 762 2 4
FUROSEMIDE 883 790 3 8
LISINOPRIL 758 618 4 3
OMEPRAZOLE 750 566 5 5
SIMVASTATIN 711 567 6 2
CITALOPRAM HBR 591 558 7 18
METFORMIN HCL 574 512 8 7
GABAPENTIN 524 394 9 12
WARFARIN SODIUM 519 423 10 13
LANTUS 518 449 11 40
POLYETHYLENE GLYCOL 3350 506 447 12 42
METOPROLOL TARTRATE 506 415 12 9
BUMETANIDE 493 426 14 70
POTASSIUM CHLORIDE 488 449 15 16
ESCITALOPRAM OXALATE 477 460 16 73
CYMBALTA 441 323 17 44
IPRATROPIUM-ALBUTEROL 420 382 18 136
AMLODIPINE BESYLATE 395 364 19 6
DIVALPROEX SODIUM 368 336 20 81
DONEPEZIL HCL 363 351 21 28
ISOSORBIDE MONONITRATE ER 326 312 22 38
CARVEDILOL 323 259 23 26
NYSTATIN 318 225 24 100
TAMSULOSIN HCL 303 286 25 30
RANITIDINE HCL 299 247 26 25
NAMENDA 280 268 27 37
JANUVIA 243 234 28 98
FENTANYL 242 137 S2 29 48
ATORVASTATIN CALCIUM 229 169 30 19
GLIPIZIDE 222 193 31 51
PRAVASTATIN SODIUM 222 180 31 14
ALENDRONATE SODIUM 212 211 33 29
NOVOLOG 203 168 34 89
TRAMADOL HCL 202 181 35 15
ATENOLOL 201 174 36 11
CLOTRIMAZOLE-BETAMETHASONE 187 128 37 138
QUETIAPINE FUMARATE 187 145 37 66
RAMIPRIL 180 177 39 111
SILVER SULFADIAZINE 173 118 40 313
CLOPIDOGREL 172 158 41 39
DILTIAZEM 24HR CD 170 152 42 124
SPIRIVA 168 142 43 45
FINASTERIDE 162 150 44 103
KLOR-CON M20 161 147 45 86
LIDODERM 159 145 46 80
LOSARTAN POTASSIUM 159 143 46 20
MELOXICAM 157 148 48 36
MIRTAZAPINE 152 152 49 52
FLUTICASONE PROPIONATE 150 122 50 31
NYSTOP 150 145 50 163
CEFTRIAXONE 148 123 52 188
METOPROLOL SUCCINATE 147 145 53 17
MORPHINE SULFATE ER 146 106 S2 54 58
SERTRALINE HCL 143 125 55 23
EXELON 142 142 56 150
PREDNISONE 132 125 57 34
ROPINIROLE HCL 131 74 58 102
RISPERIDONE 131 97 58 65
NAPROXEN 126 66 60 76
PLAVIX 124 123 61 75
ALLOPURINOL 118 109 62 35
ABILIFY 117 64 63 130
CEPHALEXIN 115 89 64 74
LEVETIRACETAM 114 61 65 96
SPIRONOLACTONE 111 96 66 78
SINGULAIR 110 96 67 120
AZITHROMYCIN 106 82 68 33
CARBIDOPA-LEVODOPA 105 105 69 97
PAROXETINE HCL 103 48 70 62
FAMOTIDINE 101 59 71 68
DOXYCYCLINE HYCLATE 101 77 71 122
ADVAIR DISKUS 100 68 73 41
OXYBUTYNIN CHLORIDE ER 99 72 74 110
ZOLPIDEM TARTRATE 97 59 75 21
CIPROFLOXACIN HCL 95 84 76 59
CYCLOBENZAPRINE HCL 95 34 R 76 43
HYDROCHLOROTHIAZIDE 93 71 78 10
IBUPROFEN 92 62 79 32
CRESTOR 90 66 80 47
TRAZODONE HCL 89 62 81 46
QVAR 88 86 82 151
PHENYTOIN SODIUM EXTENDED 85 73 83 135
DIOVAN 82 81 84 123
CLONIDINE HCL 81 55 85 56
DIGOXIN 75 58 86 71
PROAIR HFA 75 43 86 27
IPRATROPIUM BROMIDE 73 43 88 164
VICTOZA 2-PAK 72 51 89 432
SEROQUEL 72 57 89 149
LAMOTRIGINE 70 23 91 185
GLIMEPIRIDE 70 70 91 57
ACETAMINOPHEN-CODEINE 70 65 S3 91 60
VENLAFAXINE HCL ER 69 40 94 107
LOVAZA 68 52 95 146
SSD 67 35 96 439
LATANOPROST 65 53 97 184
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 60 97 22
MONTELUKAST SODIUM 65 57 97 213
ALBUTEROL SULFATE 61 47 100 93
METHADONE HCL 60 49 S2 101 67
OLANZAPINE 60 46 101 115
LYRICA 60 55 101 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 47 104 91
LEVEMIR 59 54 104 171
OXYCODONE HCL-ACETAMINOPHEN 57 13 S2 106 106
OXYBUTYNIN CHLORIDE 56 52 107 92
LIDOCAINE HCL 55 52 108 269
METOCLOPRAMIDE HCL 54 0 109 181
VENTOLIN HFA 54 23 109 63
INSULIN SYRINGE 51 41 111 109
PANTOPRAZOLE SODIUM 51 51 111 64
AGGRENOX 50 50 113 206
TERAZOSIN HCL 50 48 113 129
BRIMONIDINE TARTRATE 50 36 113 291
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.